Phase II trial of hypericin photodynamic therapy in patients with psoriasis.
Phase of Trial: Phase II
Latest Information Update: 22 Feb 2017
Price : $35 *
At a glance
- Drugs Hypericin (Primary)
- Indications Psoriasis
- Focus Proof of concept; Therapeutic Use
- 22 Feb 2017 According to Soligenix media release, positive results were published in the Journal of the American Academy of Dermatology.
- 16 Sep 2014 New trial record
- 05 Sep 2014 Results published in the Media Release.